Mary Whitfill Roeloffs, Forbes Staff

Author's posts

AstraZeneca Settles Lawsuits Alleging Heartburn Drugs Caused Kidney Disease For $425 Million

The payout will settle the claims of 11,000 people who said they weren’t property warned Nexium and Prilosec could cause chronic kidney disease.

Study Shows 1,100% Spike In Mississippi Babies Born With Syphilis—It’s Also Rising In These Other States

The treatable disease is rebounding due to factors including a lack of STD prevention and inconsistent healthcare coverage.

What Is Progressive Supranuclear Palsy? Lawmaker Calls Her Rare Neurological Disorder ‘Parkinson’s On Steroids.’

A representative from Virginia was first diagnosed with Parkinson’s disease, which is much more common and affects patients similarly to supranuclear palsy.

Did Tobacco Companies Also Get Us Hooked On Junk Food? New Research Says Yes

Junk food brands like Oreo, Ritz, Miracle Whip and Oscar Meyer were once owned by tobacco companies who introduced hyperpalatable items to the American food chain.

These 10 Medications Targeted For Lower Costs By White House

Medications that treat conditions like diabetes, heart failure and cancer are among those chosen for price negotiations.

Prescriptions For Produce? Patient Health Improves When Programs Pay For Fruits And Veggies, New Study Says

Those who participated in produce prescription programs had improved BMI, blood sugar and blood pressure levels.

Michigan Teen Who Died 3 Days After Covid Vaccination Actually Killed By Bacterial Infection, CDC Reportedly Finds

A CDC report says Jacob Clynick did not die of vaccine-related causes, the Detroit Free Press reported Thursday, but the medical examiner who performed his autopsy stands by his findings.

Major Insurer Blue Shield Of California Drops CVS For Amazon, Cuban’s Cost Plus Drugs In Cost-Cutting Move

Cost Plus Drug Company, Abarca and Amazon Pharmacy will replace a majority of the services currently provided by CVS Caremark.

Biogen Looks To Bulk Up Rare Disease Portfolio With $7.3 Billion Acquisition

Biogen will buy Reata Pharmaceuticals and its Friedreich’s ataxia drug in a $7.3 billion deal.

AI At The Doctor? Amazon Launches New Service As Google, Microsoft Aim At Merging Healthcare With Artificial Intelligence

Amazon is continuing its expansion into the health space with the launch of a new generative AI tool called HealthScribe, meant to take over some time-consuming administrative tasks of doctor’s offices and clinics, the company said.